Handles budgeting, performance management, financial statements and disclosure, closing, tax work, finance-related制度対応, and standalone capital adequacy ratio reporting.
About this role
Evaluate and manage biotechnology and drug-development investments at DCI Partners through a group-company secondment. The portfolio focus is private biotech ventures, particularly in Japan and Taiwan.
Responsibilities span sourcing, scientific and commercial due diligence, valuation, negotiations, portfolio support and IPO or M&A exit planning. You will also prepare Japanese/English investor materials and support LP relationships. Applicants need life-sciences and drug-development knowledge, business English, finance and investment knowledge, relevant professional experience, and strong documentation and client-facing skills.
This is an AI-generated summary of the employer's original posting — details can be incomplete, out of date or simply wrong. Always confirm everything on the official posting before applying.